Abnormalities of the FHIT gene in human oral carcinogenesis

British Journal of Cancer

Volumn 82, Issue 4, 2000, Pages 838-843

  Tanimoto, K ^a,c   Hayashi, S ^b   Tsuchiya, E ^b   Tokuchi, Y ^b   Kobayashi, Y ^b   Yoshiga, K ^a   Okui, T ^a   Kobayashi, M ^a   Ichikawa, T ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

FHIT; Gene alteration; Microdissection; Oral leukoplakia; Oral SCC

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN;

ADULT; AGED; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CLINICAL ARTICLE; ERYTHROPLASIA; EXON; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MOUTH CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0033953917     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1009     Document Type: Article

References (27)

1. Ah-See KW, Cooke TG, Pickford IR, Soutar D and Balmain A (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621
2. Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Ohta M and Huebner K (1996) Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′, 5‴-P1.P3-triphosphate hydrolase. Biochemistry 35: 11529-11535
3. Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H and Drabkin HA (1997) Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 6: 193-203
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162: 156-159
5. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF and Minna JD (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57: 2256-2267
6. Gupta SK, Douglas-Jones AG and Morgan JM (1997) Microdissection of stained archival tissue. Mol Pathol 50: 218-220
7. Hayashi SI, Tanimoto K, Hajiro-Nakanishi K, Tsuchiya F, Kurosumi M, Higashi Y, Imai K, Suga K and Nakachi K (1997) Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 57: 1981-1985
8. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD and Gazdar AF (1995) Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273: 1908
9. Johnson NW (1991) A global view of the epidemiology of oral cancer. In: Oral Cancer: The Detection of Patients and Lesions at Risk, Johnson NW (ed). pp. 3-26. Cambridge University Press: Cambridge
10. Licciardello JTW, Spitz MR and Hong WK (1989) Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus and lung. Int J Radiat Oncol Biol Phys 17: 467-476
11. Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S and Boiocchi M (1993) Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 53: 5775-5779
12. Mao L (1998) Tumor suppressor gene: does FHIT fit? J Natl Cancer Inst 90: 412-414
13. Mao L, Fan YH, Lotan R and Hong WK (1996) Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56: 5128-5131
14. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siparashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597
15. Otterson GA, Xiao GH, Geradts J, Jin F, Chen Wd, Niklinska W, Kaye FJ and Yeung RS (1998) Protein expression and functional analysis of the FHIT gene in human tumor cells. Int Natl Cancer Inst 90: 426-432
16. Panagopoulos I, Thelin S, Mertens F, Mitelman F and Aman P (1997) Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 19: 215-219
17. Papadimitrakopoulou VA, Shin DM and Hong WK (1996) Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis. Cancer Metastasis Rev 15: 53-76
18. Silverman S Jr, Gorsky M and Lozada F (1984) Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53: 563-568
19. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM and Huebner K (1997) Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94: 13771-13776
20. Slaughter DP, Southwick HW and Smejkal W (1953) 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6: 963-968
21. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K and Croce CM (1996) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85: 17-26
22. Sozzi G, Sard L, De Gregorio L, Marchetti A, Musso K, Buttitta F, Tornielli S, Pellegrini S, Veronese ML, Manenti G, Incarbone M, Chella A, Angeletti CA, Pastorino U, Huebner K, Bevilaqua G, Pilotti S, Croce CM and Pierotti MA (1997) Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 57: 2121-2123
23. Takezaki T, Hirose K, Inoue M, Hamajima N, Kuroishi T, Nakamura S, Koshikawa T, Matsuura H and Tajima K (1996) Tobacco, alcohol and dietary factors associated with the risk of oral cancer among Japanese. Jpn J Cancer Res 87: 555-562
24. Tanimoto K, Hayashi SI, Yoshiga K and Ichikawa T (1999) Polymorphisms of the CYPIAI and GSTMI gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 35: 191-196
25. Todd R, Donoff RB and Wong DTW (1997) The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg 55: 613-623
26. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H and Kitagawa T (1992) Allelotype of non-small-cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52: 2478-2481
27. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K and Croce CM (1996) FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93: 9770-9775